LawLinter
Back to search
HR 6109 - 118

PILLS Act

Referred to the Subcommittee on Health.

Bill Text Stats

8
Analyzed sections
N/A
Detected dollar total
25
Tax signals
2
Deadlines

Signal counts

Tax density 312.5%
Spending density 0.0%
Tax 25
Amendments 5
Statutory Reference 5
Deadline 2

Top agencies

N/A

Statutory references

15 U.S.C. 4651 2
42 U.S.C. 262 2
21 U.S.C. 355 1

Affected Sectors

How to read this

Sectors are deterministic matches from official Congress.gov data and cached bill text. They are source-derived signals, not conclusions about intent or economic effect.

Evidence matches count official fields, normalized subjects, cached text snippets, or extracted entities that matched the sector rules.

Impact is a bill-level rollup used for sorting and filtering. It is not an economic impact estimate.

Confidence is the strongest individual match score behind that sector.

Evidence snippets show why a sector matched and can repeat when Congress.gov repeats the same phrase across official fields.

Finance and banking
26 evidence matches
Impact 100% Confidence 74%

Elective Payment.--Section 6417(a) of the Internal Revenue Code of 1986 is amended by adding at the end the following new paragraph: ``(13) The generic drugs and biosimilars production credit determined under section 45BB.''. (c) Conforming

A of chapter 1 of the Internal Revenue Code of 1986 is amended by adding at the end the following new item: ``Sec. 45BB. Generic drugs and biosimilars production credit.''. (d) Effective Date.--The amendments made by this section shall appl

is amended by SEC. 3. GENERIC DRUGS AND BIOSIMILARS INVESTMENT CREDIT. (a) In General.--Subpart E of part IV of subchapter A of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after

Healthcare
11 evidence matches
Impact 100% Confidence 80%

42 U.S.C. 262 biological product has the meaning given such term in section 351(i)(1) of the Public Health Service Act ( 42 U.S.C. 262(i)(1) ). /p

42 U.S.C. 262 a biological product for which a biologics license has been issued under section 351(k) of the Public Health Service Act ( 42 U.S.C. 262(k) ). /p

). ``(4) Biological product.--The term `biological product' has the meaning given such term in section 351(i)(1) of the Public Health Service Act (42 U.S.C. 262(i)(1)). ``(5) Licensed biosimilar.--The term `licensed biosimilar' means a biol

Defense
5 evidence matches
Impact 94% Confidence 80%

15 U.S.C. 4651 s defined in section 9901(8) of the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 ( 15 U.S.C. 4651 )). /par

15 U.S.C. 4651 s defined in section 9901(8) of the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 ( 15 U.S.C. 4651 ), and /

U.S.C. 4651 was a foreign entity of concern (as defined in section 9901(8) of the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 (15 U.S.C. 4651)). ``(b) Credit Amount.-- ``(1) In general.--Subject to p

CBO Cost Estimates

Official Congressional Budget Office cost estimate links associated with this bill through Congress.gov records.

How to read this

CBO estimates are official source documents with their own assumptions, scope, and publication dates. They can score a bill, a version of a bill, or a broader legislative package.

LawLinter stores the source link from Congress.gov and does not replace the CBO document. Use these cards as pointers for source review, not as independent fiscal advice.

CBO context shows source-attributed Congressional Budget Office cost estimates linked from official Congress.gov bill records. It is research context only; read the official CBO source document for assumptions, scope, and dates.

No CBO cost estimate is currently linked for this bill.

Campaign Finance Context

Related FEC/OpenFEC campaign-finance records for lawmakers and candidates tied to this bill through source-attributed legislative relationships. These are not donations to the bill itself.

How to read this

Amounts shown here are campaign-finance totals for sponsor or cosponsor-linked candidates and their committees in the displayed FEC cycle.

They are not donations to this bill, spending on this bill, or proof that money influenced or caused sponsorship, cosponsorship, votes, or legislative outcomes.

If multiple linked lawmakers have FEC records, this section can show multiple candidate cards and separate sponsor/cosponsor rollups.

Campaign-finance context uses source-attributed FEC/OpenFEC records that are related or relevant to the displayed bill, lawmaker, candidate, committee, or legislative relationship through deterministic links. It is research context only, not proof of influence, causation, endorsement, or that money caused a sponsorship, vote, or legislative outcome.

No FEC/OpenFEC campaign-finance context is currently linked for this bill.

Lobbying Context

Related LDA.gov filings where public lobbying activity descriptions reference this bill. These records are source-attributed research context, not evidence of influence or causation.

How to read this

LDA filings are public lobbying disclosure records. LawLinter links them here only when the filing activity text contains an exact-looking reference to this bill.

A filing can mention many issues, clients, agencies, or bills. A match should be treated as a pointer for review, not as a conclusion about why legislation changed or how any lawmaker acted.

Lobbying context uses source-attributed LDA.gov records that appear related to this bill through bill references in public lobbying activity descriptions. It is research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.

No LDA.gov lobbying disclosure context is currently linked for this bill.

Summary

No official summary is currently available for this bill.

Sponsors

Timeline

Dec 17, 2024

Referred to the Subcommittee on Health.

Oct 26, 2023

Introduced in House

Oct 26, 2023

Introduced in House

Oct 26, 2023

Referred to the House Committee on Ways and Means.

House Votes

No House roll call votes have been linked to this bill yet.

Amendments

No amendment records are currently available for this bill.
Compiled bill record. Bill pages combine Congress.gov source payloads, normalized relationships, cached text analysis, vote links, and deterministic sector/signal extraction. This is not an official government record or legal advice; use the official source link when accuracy matters.
DisclaimerReport issue